On-Q-ity Ups Venture Round by $5M


Waltham, MA-based cancer diagnostics firm On-Q-ity has added a new investor and an additional $5 million to the $21 million Series A venture round it announced in early November, according to a press release summarized in the Boston Globe today. The new investor, Atlas Venture, joins Bessemer Venture Partners, MDV-Mohr Davidow Ventures, Northgate Capital, and Physic Ventures. On-Q-ity was formed earlier this year through the fusion of Mohr Davidow Ventures portfolio companies Cellective DX and The DNA Repair Company.

Wade Roush is Chief Correspondent and Editor At Large at Xconomy. You can subscribe to his Google Group or e-mail him at wroush@xconomy.com. Follow @

By posting a comment, you agree to our terms and conditions.